The cyclic AMP-lowering effect on the stable endoperoxide analog U46619 in human platelets.
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology; D011466:Prostanoic Acids / Q000494:pharmacology
D011450:Prostaglandin Endoperoxides, Synthetic; D011458:Prostaglandins E; D011466:Prostanoic Acids; C022574:13-azaprostanoic acid; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000242:Cyclic AMP; D001241:Aspirin